Artículos de revistas sobre el tema "M. smegmatis - Rifampicin"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 38 mejores artículos de revistas para su investigación sobre el tema "M. smegmatis - Rifampicin".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Do, Thi Thuy, Jerónimo Rodríguez-Beltran, Esmeralda Cebrián-Sastre, Alexandro Rodríguez-Rojas, Alfredo Castañeda-García y Jesús Blázquez. "Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in Mycobacterium smegmatis". Antibiotics 11, n.º 4 (12 de abril de 2022): 509. http://dx.doi.org/10.3390/antibiotics11040509.
Texto completoDey, Abhinav, Amit Kumar Verma y Dipankar Chatterji. "Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin". Microbiology 156, n.º 3 (1 de marzo de 2010): 873–83. http://dx.doi.org/10.1099/mic.0.033670-0.
Texto completoKurthkoti, Krishna, Thiruneelakantan Srinath, Pradeep Kumar, Vidyasagar S. Malshetty, Pau Biak Sang, Ruchi Jain, Ramanathapuram Manjunath y Umesh Varshney. "A distinct physiological role of MutY in mutation prevention in mycobacteria". Microbiology 156, n.º 1 (1 de enero de 2010): 88–93. http://dx.doi.org/10.1099/mic.0.033621-0.
Texto completoTran, Huyen Thi, Julia Solnier, Eva-Maria Pferschy-Wenzig, Olaf Kunert, Liam Martin, Sanjib Bhakta, Loi Huynh, Tri Minh Le, Rudolf Bauer y Franz Bucar. "Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus Against Mycobacteria". Antibiotics 9, n.º 7 (8 de julio de 2020): 390. http://dx.doi.org/10.3390/antibiotics9070390.
Texto completoVerma, Amit Kumar y Dipankar Chatterji. "Dual role of MsRbpA: transcription activation and rescue of transcription from the inhibitory effect of rifampicin". Microbiology 160, n.º 9 (1 de septiembre de 2014): 2018–29. http://dx.doi.org/10.1099/mic.0.079186-0.
Texto completoSolnier, Julia, Liam Martin, Sanjib Bhakta y Franz Bucar. "Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species". Molecules 25, n.º 3 (7 de febrero de 2020): 734. http://dx.doi.org/10.3390/molecules25030734.
Texto completoSachan, Tarun Kumar y Virendra Kumar. "Antibiotic Susceptibility in Biofilms of Mycobacterium smegmatis". International Journal of Applied Sciences and Biotechnology 3, n.º 4 (30 de diciembre de 2015): 635–41. http://dx.doi.org/10.3126/ijasbt.v3i4.13522.
Texto completoTamuhla, Tsaone, Lydia Joubert, Danicke Willemse y Monique J. Williams. "SufT is required for growth of Mycobacterium smegmatis under iron limiting conditions". Microbiology 166, n.º 3 (1 de marzo de 2020): 296–305. http://dx.doi.org/10.1099/mic.0.000881.
Texto completoKunota, Tafara T. R., Md Aejazur Rahman, Barry E. Truebody, Jared S. Mackenzie, Vikram Saini, Dirk A. Lamprecht, John H. Adamson et al. "Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility". Antioxidants 10, n.º 8 (13 de agosto de 2021): 1285. http://dx.doi.org/10.3390/antiox10081285.
Texto completoMalshetty, Vidyasagar, Krishna Kurthkoti, Arnab China, Bratati Mallick, Subburaj Yamunadevi, Pau Biak Sang, Narayanaswamy Srinivasan, Valakunja Nagaraja y Umesh Varshney. "Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription". Microbiology 156, n.º 5 (1 de mayo de 2010): 1565–73. http://dx.doi.org/10.1099/mic.0.036970-0.
Texto completoChandra, Harish, Seemi Farhat Basir, Manish Gupta y Nirupama Banerjee. "Glutamine synthetase encoded by glnA-1 is necessary for cell wall resistance and pathogenicity of Mycobacterium bovis". Microbiology 156, n.º 12 (1 de diciembre de 2010): 3669–77. http://dx.doi.org/10.1099/mic.0.043828-0.
Texto completoStrharsky, Tomas, Dominika Pindjakova, Jiri Kos, Lucia Vrablova, Hana Michnova, Jan Hosek, Nicol Strakova et al. "Study of Biological Activities and ADMET-Related Properties of Novel Chlorinated N-arylcinnamamides". International Journal of Molecular Sciences 23, n.º 6 (15 de marzo de 2022): 3159. http://dx.doi.org/10.3390/ijms23063159.
Texto completoObakiro, Samuel Baker, Ambrose Kiprop, Isaac K’owino, Moses Andima, Richard Oriko Owor, Robi Chacha y Elizabeth Kigondu. "Phytochemical, Cytotoxicity, and Antimycobacterial Activity Evaluation of Extracts and Compounds from the Stem Bark of Albizia coriaria Welw ex. Oliver". Evidence-Based Complementary and Alternative Medicine 2022 (22 de enero de 2022): 1–20. http://dx.doi.org/10.1155/2022/7148511.
Texto completoKisiel-Nawrot, Ewa, Dominika Pindjakova, Malgorzata Latocha, Andrzej Bak, Violetta Kozik, Kinga Suwinska, Aleksander Sochanik, Alois Cizek, Josef Jampilek y Andrzej Zięba. "Design, Synthesis and Antimicrobial Properties of New Tetracyclic Quinobenzothiazine Derivatives". International Journal of Molecular Sciences 23, n.º 23 (1 de diciembre de 2022): 15078. http://dx.doi.org/10.3390/ijms232315078.
Texto completoAlexander, David C., Joses R. W. Jones y Jun Liu. "A Rifampin-Hypersensitive Mutant Reveals Differences between Strains of Mycobacterium smegmatis and Presence of a Novel Transposon, IS1623". Antimicrobial Agents and Chemotherapy 47, n.º 10 (octubre de 2003): 3208–13. http://dx.doi.org/10.1128/aac.47.10.3208-3213.2003.
Texto completoKarunakaran, Ponniah y Julian Davies. "Genetic Antagonism and Hypermutability inMycobacterium smegmatis". Journal of Bacteriology 182, n.º 12 (15 de junio de 2000): 3331–35. http://dx.doi.org/10.1128/jb.182.12.3331-3335.2000.
Texto completoQuan, S., H. Venter y E. R. Dabbs. "Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic." Antimicrobial Agents and Chemotherapy 41, n.º 11 (noviembre de 1997): 2456–60. http://dx.doi.org/10.1128/aac.41.11.2456.
Texto completoMcDermott, Patrick F., David G. White, Isabelle Podglajen, Michael N. Alekshun y Stuart B. Levy. "Multidrug Resistance following Expression of the Escherichia coli marA Gene in Mycobacterium smegmatis". Journal of Bacteriology 180, n.º 11 (1 de junio de 1998): 2995–98. http://dx.doi.org/10.1128/jb.180.11.2995-2998.1998.
Texto completoMan, DeDe Kwun-Wai, Tokuwa Kanno, Giorgia Manzo, Brian D. Robertson, Jenny K. W. Lam y A. James Mason. "Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides". mSphere 3, n.º 4 (18 de julio de 2018): e00218-18. http://dx.doi.org/10.1128/msphere.00218-18.
Texto completoStephan, Joachim, Claudia Mailaender, Gilles Etienne, Mamadou Daffé y Michael Niederweis. "Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis". Antimicrobial Agents and Chemotherapy 48, n.º 11 (noviembre de 2004): 4163–70. http://dx.doi.org/10.1128/aac.48.11.4163-4170.2004.
Texto completoRen, Huiping y Jun Liu. "AsnB Is Involved in Natural Resistance of Mycobacterium smegmatis to Multiple Drugs". Antimicrobial Agents and Chemotherapy 50, n.º 1 (enero de 2006): 250–55. http://dx.doi.org/10.1128/aac.50.1.250-255.2006.
Texto completoDhouib, Rabeb, Françoise Laval, Frédéric Carrière, Mamadou Daffé y Stéphane Canaan. "A Monoacylglycerol Lipase from Mycobacterium smegmatis Involved in Bacterial Cell Interaction". Journal of Bacteriology 192, n.º 18 (2 de julio de 2010): 4776–85. http://dx.doi.org/10.1128/jb.00261-10.
Texto completoNaas, Thierry, Yuzuru Mikami, Tamae Imai, Laurent Poirel y Patrice Nordmann. "Characterization of In53, a Class 1 Plasmid- and Composite Transposon-Located Integron of Escherichia coli Which Carries an Unusual Array of Gene Cassettes". Journal of Bacteriology 183, n.º 1 (1 de enero de 2001): 235–49. http://dx.doi.org/10.1128/jb.183.1.235-249.2001.
Texto completoKana, Bavesh D., Garth L. Abrahams, Nackmoon Sung, Digby F. Warner, Bhavna G. Gordhan, Edith E. Machowski, Liana Tsenova et al. "Role of the DinB Homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis". Journal of Bacteriology 192, n.º 8 (5 de febrero de 2010): 2220–27. http://dx.doi.org/10.1128/jb.01135-09.
Texto completoPaul, Avraneel, Rashmi Ravindran Nair, Kishor Jakkala, Atul Pradhan y Parthasarathi Ajitkumar. "Elevated Levels of Three Reactive Oxygen Species and Fe(II) in the Antibiotic-Surviving Population of Mycobacteria Facilitate De Novo Emergence of Genetic Resisters to Antibiotics". Antimicrobial Agents and Chemotherapy, 18 de abril de 2022. http://dx.doi.org/10.1128/aac.02285-21.
Texto completoPradhan, Suchitra, Shwetha K., Pratibha Kumari y Ravi Kumar. "Biochemical and functional characterization of the SMC holocomplex from Mycobacterium smegmatis". Microbiology, 22 de diciembre de 2020. http://dx.doi.org/10.1099/mic.0.001011.
Texto completoGiddey, Alexander D., Tariq A. Ganief, Naadir Ganief, Anastasia Koch, Digby F. Warner, Nelson C. Soares y Jonathan M. Blackburn. "Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure". Frontiers in Medicine 8 (5 de octubre de 2021). http://dx.doi.org/10.3389/fmed.2021.723667.
Texto completoGiddey, Alexander D., Tariq A. Ganief, Naadir Ganief, Anastasia Koch, Digby F. Warner, Nelson C. Soares y Jonathan M. Blackburn. "Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure". Frontiers in Medicine 8 (5 de octubre de 2021). http://dx.doi.org/10.3389/fmed.2021.723667.
Texto completoFaulkner, Valwynne, Adrienne Adele Cox, Shan Goh, Annelies van Bohemen, Amanda J. Gibson, Oliver Liebster, Brendan W. Wren, Sam Willcocks y Sharon L. Kendall. "Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits". Frontiers in Microbiology 11 (1 de febrero de 2021). http://dx.doi.org/10.3389/fmicb.2020.619427.
Texto completoRai, Deepika y Sarika Mehra. "The mycobacterial efflux pump EfpA can induce high drug tolerance to many anti-tuberculosis drugs, including moxifloxacin, in Mycobacterium smegmatis". Antimicrobial Agents and Chemotherapy, 23 de agosto de 2021. http://dx.doi.org/10.1128/aac.00262-21.
Texto completoDe Siena, Barbara, Nicoletta Campolattano, Gianluca D’Abrosca, Luigi Russo, Daire Cantillon, Rosangela Marasco, Lidia Muscariello, Simon J. Waddell y Margherita Sacco. "Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux". Frontiers in Microbiology 11 (3 de diciembre de 2020). http://dx.doi.org/10.3389/fmicb.2020.575828.
Texto completoJakkala, Kishor, Avraneel Paul, Atul Pradhan, Rashmi Ravindran Nair, Deepti Sharan, Sharmada Swaminath y Parthasarathi Ajitkumar. "Unique Mode of Cell Division by the Mycobacterial Genetic Resister Clones Emerging De Novo from the Antibiotic-Surviving Population". mSphere 5, n.º 6 (18 de noviembre de 2020). http://dx.doi.org/10.1128/msphere.00994-20.
Texto completoPradhan, Atul, Sharmada Swaminath, Kishor Jakkala y Parthasarathi Ajitkumar. "A method for the enrichment, isolation and validation of Mycobacterium smegmatis population surviving in the presence of bactericidal concentrations of rifampicin and moxifloxacin". FEMS Microbiology Letters 368, n.º 14 (julio de 2021). http://dx.doi.org/10.1093/femsle/fnab090.
Texto completoShen, Hongbo, Feifei Wang, Gucheng Zeng, Ling Shen, Han Cheng, Dan Huang, Richard Wang, Lijun Rong y Zheng W. Chen. "Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice". Scientific Reports 6, n.º 1 (7 de septiembre de 2016). http://dx.doi.org/10.1038/srep32725.
Texto completoKalapala, Yeswanth Chakravarthy, Pallavi Raj Sharma y Rachit Agarwal. "Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions". Frontiers in Microbiology 11 (14 de diciembre de 2020). http://dx.doi.org/10.3389/fmicb.2020.583661.
Texto completoMaeda, Tomoya, Masako Kawada, Natsue Sakata, Hazuki Kotani y Chikara Furusawa. "Laboratory evolution of Mycobacterium on agar plates for analysis of resistance acquisition and drug sensitivity profiles". Scientific Reports 11, n.º 1 (23 de julio de 2021). http://dx.doi.org/10.1038/s41598-021-94645-z.
Texto completoFishbein, Skye R. S., Francesca G. Tomasi, Ian D. Wolf, Charles L. Dulberger, Albert Wang, Hasmik Keshishian, Luke Wallace et al. "The conserved translation factor LepA is required for optimal synthesis of a porin family in Mycobacterium smegmatis". Journal of Bacteriology, 23 de diciembre de 2020. http://dx.doi.org/10.1128/jb.00604-20.
Texto completoEaland, Christopher, Binayak Rimal, James Chang, Lethabo Mashigo, Melissa Chengalroyen, Lusanda Mapela, Germar Beukes, Edith Machowski, Sung Joon Kim y Bavesh Kana. "Resuscitation-Promoting Factors Are Required for Mycobacterium smegmatis Biofilm Formation". Applied and Environmental Microbiology 84, n.º 17 (18 de junio de 2018). http://dx.doi.org/10.1128/aem.00687-18.
Texto completo